Presentation is loading. Please wait.

Presentation is loading. Please wait.

Impact of ASPAN’s Evidence-based Clinical Practice Guideline for the Prevention and/or Treatment of PONV/PDNV Corey R. Peterson DNP, CRNA, Lisa Stephens,

Similar presentations


Presentation on theme: "Impact of ASPAN’s Evidence-based Clinical Practice Guideline for the Prevention and/or Treatment of PONV/PDNV Corey R. Peterson DNP, CRNA, Lisa Stephens,"— Presentation transcript:

1 Impact of ASPAN’s Evidence-based Clinical Practice Guideline for the Prevention and/or Treatment of PONV/PDNV Corey R. Peterson DNP, CRNA, Lisa Stephens, DNP, CRNA, Marguerite Murphy, DNP, RN, Vallire Hooper, PhD, RN, CPAN, FAAN, Jan Odom-Forren, PhD, RN, CPAN, FAAN

2 Postoperative & Postdischarge Nausea and Vomiting (PONV/PDNV)
53 million ambulatory surgeries annually National Health Statistics Report (2009) 30% - 50% incidence of PDNV (16 – million incidents) Apfel et al., (2004) Threats associated with PONV/PDNV − Pt dissatisfaction − Increased pain − MI − Wound dehiscence − Aspiration −Delayed discharge − Delayed return to function -Increased costs − Noncompliance w/discharge instruction Apfel et al., (2002)

3 Postoperative & Postdischarge Nausea and Vomiting (PONV/PDNV)
Is a common anesthesia complication Apfel et al., (1999) Is the most feared anesthesia complication by patients Awad (2006) Is a complex physiologic phenomena Hornby, (2001) Is largely preventable and treatable Habib et al, (2004)

4 PONV/PDNV PONV – first 24 hrs post – op PDNV – after discharge
Predictable risk factors exist for PONV/PDNV Apfel et al.(2002) Efficacious pharmacological interventions exist for PONV/PDNV Gan et al., (2007); Odom-Forren et al., (2006)

5 Evidenced-Based Clinical Practice Guidelines (EBCPG)
In 2006 the American Society of PeriAnesthesia Nurses (ASPAN) published EBCPG for the prevention and/or treatment of PONV/PDNV ASPAN (2006) ASPAN guidelines base the number of interventions given on a patient’s risk of PONV/PDNV ASPAN guidelines are Evidenced-based Patient focused Multidisciplinary Cost conscience

6 Problem Statement PONV/PDNV is an ongoing complication
Efficacious interventions exist to prevent and/or manage PONV/PDNV High quality EBCPG exist to guide anesthesia providers in the prevention and/or management of PONV/PDNV No information exists regarding the level of adoption of these EBCPG by anesthesia providers

7 From The Literature EBCPG are effective and efficacious tools to improve healthcare delivery Implementation of EBCPG is a complex process PONV/PDNV is a common, significant complication of general anesthesia High quality EBCPG exist to prevent and treat PONV/PDNV

8 Areas Of Inquiry What is the degree of adoption of the recommendations of the ASPAN PONV/PDNV guidelines Is there a relationship between the appropriate application of the ASPAN guidelines and the incidence of PDNV Is there a relationship between the incidence of PONV and the incidence of PDNV Is there a cost savings associated with the use of the ASPAN guidelines

9 Methodology Secondary data analysis (N=94) Primary Study
Primary Aim – to determine independent predictors of PDNV Study Design Multi-site prospective survey No prescribed treatment regimen Targeted sample size ~2000

10 Demographic Information
Age (Mean ± SD) 43 years ± 12.9 years Race (N, %) African American 29/30.9 Caucasian 55/58.5 Latino 1/1.1 Other 9/9.6 ASA Physical Status (N,%) I 20/21.3 II 58/61.7 III 16/17.0

11 Surgical Information Type Of Surgery (N,%) General 13/13.8 ENT 23/24.5
Gynecological 12/12.8 Orthopedic 33/35.1 Urologic 4/4.3 Other 9/9.6 Duration (hrs.) (Mean ± SD) 1.7 ± 0.8

12 PONV/PDNV Risk Distribution
Risk Factor Incidence (N/%) Female Gender 66/70.2 Non-smoker 76/80.9 Hx PONV or MS 47/50 Post-op Opioids Total Risk Factors Per Subject Number of Subjects (N/%) 0 (Low Risk) 2/2.1 1 (Low Risk) 11/11.7 2 (Moderate Risk) 23/24.5 3 (Severe Risk) 34/36.2 4 (Very Severe Risk) 24/25.5

13 Interventions Recommended vs. Administered
Level of Risk Drugs Recommended Drugs Administered (Mean ± SD) Low 1.07 ± 0.64 Moderate 1 1.30 ± 0.93 Severe 2 1.56 ± 0.82 Very Severe 3 + 1.58 ± 0.76 Pearson’s product-moment correlation (r) = 0.21, N = 94, p = 0.004

14 PONV & PDNV Incidence Treatment Group (N=94) Cases (N/%)
Incidence of PONV (N/%) Incidence of PDNV (N/%) Undertreatment 41/44 13/32 30/73 Followed Guidelines 30/32 6/20 18/60 Overtreatment 23/24 2/9 10/43 Overall Incidence 21/22.3 58/61.7

15 Discussion Poor degree of adoption of the guidelines
68% NOT treated according to the guidelines 32% treated according to guidelines Majority of patients received a single intervention Higher risk tended to be undertreated Lower risk tended to be overtreated Pearson product-moment correlation r=0.21 N=94 p=.004

16 Discussion Poor guideline adoption is consistent with recent research
McMenamin et al.(2010). Chamie et al. (2011). Shirvani et al. (2011). Bhattacharyya et al. (2010). Kooij et al. (2010). Franck et al. (2010). White et al (2008).

17 Discussion Poor adoption of the ASPAN guidelines made it impossible to determine the efficacy of the guidelines Trends Patients with higher risks received more interventions Patients who received more interventions had a lower incidence of PONV & PDNV

18 Discussion Incidence of PDNV was over 60%
Incidence of PDNV was 2 – 3 times the incidence of PONV No additional interventions for PDNV Short duration of action of antiemetics Longer reporting period for PDNV

19 Discussion Institutional antiemetic costs
Ondansetron $ Metaclopromide $0.29 Diphenhydramine $ Promethazine $0.46 Dexamethazone $ Compazine $1.89 Scopolamine Patch $10.14 (A. Barnett, personal communications, September 5, 2011) Institutional cost of antiemetic drug are insignificant in relation to other health care cost

20 Practice Implications
Given Poor adoption of even simple, well supported EBCPG The more antiemetics given the lower the incidence of PONV/PDNV Current first-line antiemetics have excellent safety profiles and negligible costs Is it time to revise the ASPAN guidelines to recommend every patient receives the maximum number of antiemetics regardless of their risk?

21 References Bhattacharyya, P., Paul, R., Nag, S., Bardhan, S., Saha, I., Ghosh, M., Acharyya Ghosh, D. (2010). Treatment of asthma: Identification of the practice behavior and the deviation from the guideline recommendations. Lung India, 27(3), doi: / Chamie, K., Saigal, C. S., Lai, J., Hanley, J. M., Setodji, C. M., Konety, B. R., & Litwin, M. S. (2011). Compliance with guidelines for patients with bladder cancer: Variation in the Delivery of Care. Cancer. doi: /cncr.26198 Fineout-Overholt, E. (2008). Synthesizing the evidence: how far can your confidence meter take you? AACN Adv Crit Care, 19(3), Franck, M., Radtke, F. M., Baumeyer, A., Kranke, P., Wernecke, K. D., & Spies, C. D. (2010). [Adherence to treatment guidelines for postoperative nausea and vomiting. How well does knowledge transfer result in improved clinical care?]. Anaesthesist, 59(6), doi: /s z Frenzel, J. C., Kee, S. S., Ensor, J. E., Riedel, B. J., & Ruiz, J. R. (2010). Ongoing provision of individual clinician performance data improves practice behavior. Anesth Analg, 111(2), doi: ANE.0b013e3181dd5899 [pii]

22 References Gan, T. J., Meyer, T. A., Apfel, C. C., Chung, F., Davis, P. J., Habib, A. S., Watcha, M. (2007). Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg, 105(6), Ginn, M. B., Cox, G., & Heath, J. (2008). Evidence-based approach to an inpatient tobacco cessation protocol. AACN Adv Crit Care, 19(3), ; quiz Glickman, S. W., Baggett, K. A., Krubert, C. G., Peterson, E. D., & Schulman, K. A. (2007). Promoting quality: the health-care organization from a management perspective. Int J Qual Health Care, 19(6), Grimshaw, J., Eccles, M., & Tetroe, J. (2004). Implementing clinical guidelines: current evidence and future implications. J Contin Educ Health Prof, 24 Suppl 1, S31-37. Guyatt, G. H., Naylor, D., Richardson, W. S., Green, L., Haynes, R. B., Wilson, M. C., Jaeschke, R. Z. (2000). What is the best evidence for making clinical decisions? JAMA, 284(24), Habib, A. S., White, W. D., Eubanks, S., Pappas, T. N., & Gan, T. J. (2004). A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting. Anesth Analg, 99(1),

23 References Hornby, P. J. (2001). Central neurocircuitry associated with emesis. Am J Med, 111 Suppl 8A, 106S-112S. Instutute of Medicine. (2008). Knowing what works in health care: A roadmap for the nation. Retrieved from Care-A-Roadmap-for-the-Nation.aspx. Joy-Joseph, L., Colin, J. M., Rosenstein, C. R., & Chinye-Onyejuruwa, F. (2010). An evidence-based approach for managing catheter- associated bloodstream infection in a level II neonatal intensive care unit. J Nurs Care Qual, 25(2), Johnston, L., & Fineout-Overholt, E. (2006). Teaching EBP: the critical step of critically appraising the literature. Worldviews Evid Based Nurs, 3(1), Jones, K. R. (2010). Rating the level, quality, and strength of the research evidence. J Nurs Care Qual, 25(4), Kooij, F. O., Klok, T., Hollmann, M. W., & Kal, J. E. (2010). Automated reminders increase adherence to guidelines for administration of prophylaxis for postoperative nausea and vomiting. Eur J Anaesthesiol, 27(2), doi: /EJA.0b013e32832d6a76

24 References McGlynn, E. A., Asch, S. M., Adams, J., Keesey, J., Hicks, J., DeCristofaro, A., & Kerr, E. A. (2003). The quality of health care delivered to adults in the United States. N Engl J Med, 348(26), McMenamin, S. B., Bellows, N. M., Halpin, H. A., Rittenhouse, D. R., Casalino, L. P., & Shortell, S. M. (2010). Adoption of policies to treat tobacco dependence in U.S. medical groups. Am J Prev Med, 39(5), doi: S (10) [pii] Odom-Forren, J., Fetzer, S. J., & Moser, D. K. (2006). Evidence-based interventions for post discharge nausea and vomiting: a review of the literature. J Perianesth Nurs, 21(6), Prior, M., Guerin, M., & Grimmer-Somers, K. (2008). The effectiveness of clinical guideline implementation strategies--a synthesis of systematic review findings. J Eval Clin Pract, 14(5), Rosenbrand, K., Van Croonenborg, J., & Wittenberg, J. (2008). Guideline development. Stud Health Technol Inform, 139, 3-21. Shirvani, S. M., Pan, I. W., Buchholz, T. A., Shih, Y. C., Hoffman, K. E., Giordano, S. H., & Smith, B. D. (2011). Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women. Cancer. doi: /cncr.26081

25 References Shortell, S. M., Rundall, T. G., & Hsu, J. (2007). Improving patient care by linking evidence-based medicine and evidence-based management. JAMA, 298(6), Titler, M. (2007). Translating research into practice. Am J Nurs, 107(6 Suppl), 26-33; quiz 33. White, P. F., O'Hara, J. F., Roberson, C. R., Wender, R. H., & Candiotti, K. A. (2008).The impact of current antiemetic practices on patient outcomes: a prospective study on high- risk patients. Anesth Analg, 107(2), doi: 107/2/452 [pii] Wu, C. L., Berenholtz, S. M., Pronovost, P. J., & Fleisher, L. A. (2002). Systematic review and analysis of postdischarge symptoms after outpatient surgery. Anesthesiology, 96(4),


Download ppt "Impact of ASPAN’s Evidence-based Clinical Practice Guideline for the Prevention and/or Treatment of PONV/PDNV Corey R. Peterson DNP, CRNA, Lisa Stephens,"

Similar presentations


Ads by Google